Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shigeta

Showing results (241-250 of 281) with videos related to

Pageof 29
Sort By:
The Japanese Journal of Antibiotics|November 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). II. Background of patients]Y Kumamoto, T Hirose, N Tanaka, et al.
The Japanese Journal of Antibiotics|October 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). II. Background of patients]Y Kumamoto, T Hirose, N Tanaka, et al.
The Japanese Journal of Antibiotics|November 1, 1986
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution]N Kosakai, Y Kumamoto, S Sakai, et al.
Japanese Journal of Cancer Research : Gann|August 1, 1987
A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modificationH Nakashima, T Matsui, O Yoshida, et al.
The Japanese Journal of Antibiotics|December 1, 1987
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution]N Kosakai, Y Kumamoto, S Sakai, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetateM Fujiwara, K Ijichi, K Tokuhisa, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1991
Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compoundsE De Clercq, M Cools, J Balzarini, et al.
Archives of Virology|December 18, 1998
Upregulation of HIV-1 replication in chronically infected cells by ingenol derivativesM Fujiwara, M Okamoto, K Ijichi, et al.
Journal of Medicinal Chemistry|January 24, 1992
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityH Tanaka, H Takashima, M Ubasawa, et al.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:
Pageof 29
The Japanese Journal of Antibiotics|November 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). II. Background of patients]Y Kumamoto, T Hirose, N Tanaka, et al.
The Japanese Journal of Antibiotics|October 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). II. Background of patients]Y Kumamoto, T Hirose, N Tanaka, et al.
The Japanese Journal of Antibiotics|November 1, 1986
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution]N Kosakai, Y Kumamoto, S Sakai, et al.
Japanese Journal of Cancer Research : Gann|August 1, 1987
A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modificationH Nakashima, T Matsui, O Yoshida, et al.
The Japanese Journal of Antibiotics|December 1, 1987
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution]N Kosakai, Y Kumamoto, S Sakai, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetateM Fujiwara, K Ijichi, K Tokuhisa, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1991
Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compoundsE De Clercq, M Cools, J Balzarini, et al.
Archives of Virology|December 18, 1998
Upregulation of HIV-1 replication in chronically infected cells by ingenol derivativesM Fujiwara, M Okamoto, K Ijichi, et al.
Journal of Medicinal Chemistry|January 24, 1992
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityH Tanaka, H Takashima, M Ubasawa, et al.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Pageof 29